Fulcrum Therapeutics, Inc. (FULC)

CIK 1680581 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Fulcrum Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 2026EFFECT9999999995-26-003437
Nov 4, 2026424B30001193125-26-447368
Nov 3, 2026S-4/A0001193125-26-444432
Oct 28, 2026SCHEDULE 13G/A0000070858-26-000532
Oct 27, 2026SCHEDULE 13G/A0002052113-26-001118
Oct 20, 2026S-4/A0001193125-26-426840
Oct 8, 2026S-4/A0001193125-26-418056
Sep 2, 20261440001193125-26-379476
Sep 2, 2026S-40001193125-26-379106
Aug 17, 20264250001193125-26-353280
Aug 17, 20264250001193125-26-354107
Aug 17, 20264250001193125-26-353282
Aug 17, 20268-K0001193125-26-353278
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000923
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352345
Aug 14, 2026SCHEDULE 13G0001104659-26-097278
Aug 14, 2026SCHEDULE 13G/A0000919574-26-005528
Aug 10, 20268-K0001193125-26-341385
Aug 3, 2026SCHEDULE 13G0000070858-26-000396
Jul 30, 202610-Q0001193125-26-326098
Jul 28, 2026SCHEDULE 13G/A0002012383-26-002576
Jul 20, 202640001178579-26-000016
Jul 17, 2026SCHEDULE 13G0002052113-26-000745
Jul 15, 2026SCHEDULE 13G/A0001214659-26-008613
Jul 15, 202640001178579-26-000014